CNX-013

N/A

Report date: 2025/06/11 11:00:44
NME

Base Information

Drug NameCNX-013
Drug Alias NameCNX-013-B2CNX-013
ClassificationSmall molecules
Mechanisms of ActionRetinoid X receptor alpha agonistsApoptosis inhibitorsInsulin sensitizers +[4] 
TargetsRetinoid X receptor alpha
Therapy Area/IndicationsCachexiaLipid Metabolism DisordersDiabetes Mellitus, Type 2 +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesConnexios Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesConnexios Life Sciences
Inactive CompaniesN/A
Active IndicationsCachexiaDiabetes Mellitus, Type 2Alzheimer Disease +[5] 
Inactive IndicationsLipid Metabolism Disorders

Other Information

ATC CodeN/A
Related LinksN/A